Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Anpac Bio-Medical Science CO ADR (ANPC)

Anpac Bio-Medical Science CO ADR (ANPC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,092
  • Shares Outstanding, K 14,763
  • Annual Sales, $ 3,140 K
  • Annual Income, $ -12,330 K
  • 60-Month Beta 1.65
  • Price/Sales 3.52
  • Price/Cash Flow N/A
  • Price/Book 20.65
Trade ANPC with:

Options Overview Details

View History
  • Implied Volatility 168.52% ( -3.29%)
  • Historical Volatility 69.68%
  • IV Percentile 59%
  • IV Rank 14.98%
  • IV High 986.63% on 12/21/21
  • IV Low 24.34% on 11/09/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 86
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,111
  • Open Int (30-Day) 490

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0100 +13.37%
on 12/23/21
1.3500 -15.19%
on 01/04/22
+0.0750 (+7.01%)
since 12/20/21
3-Month
1.0100 +13.37%
on 12/23/21
2.9100 -60.65%
on 10/21/21
-1.6350 (-58.81%)
since 10/20/21
52-Week
1.0100 +13.37%
on 12/23/21
12.0900 -90.53%
on 03/09/21
-4.7050 (-80.43%)
since 01/20/21

Most Recent Stories

More News
AnPac Bio Class III Medical Device Passes Extensive NMPA Registration Tests and Will Start Clinical Trial in Q1, 2022

PHILADELPHIA, Jan. 04, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a US and China-based...

ANPC : 1.1500 (+5.50%)
BioMedNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Publication of Technical Paper on Biophysics-Based CDA Cancer Detection Technology

AnPac Bio (NASDAQ: ANPC) , a biotechnology company with operations in China and the United States, today announced that its joint technical paper on novel Cancer Differentiation Analysis (“CDA”) Technology...

ANPC : 1.1500 (+5.50%)
Technical Paper on AnPac Bio Novel CDA Cancer Detection Technology Published by Peer-Reviewed International Medical Journal

PHILADELPHIA, Dec. 10, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology...

ANPC : 1.1500 (+5.50%)
Data Analytics Show Decline in Cancer Screening in 2020

Most patients put off  going to the doctor  or skipped undergoing checkups because of the coronavirus pandemic last year. Despite infection cases dropping and vaccine rollout, data analytics still show...

ANPC : 1.1500 (+5.50%)
BioMedNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Releases Financial, Operations Report for Latest Period

AnPac Bio-Medical Science (NASDAQ: ANPC) , a biotechnology company with operations in China and the United States focused on early cancer screening and detection, has reported its unaudited financial results...

ANPC : 1.1500 (+5.50%)
AI Solutions May Make Screening for Breast Cancer More Affordable, Accessible

Research has found that breast cancer is the most  commonly diagnosed cancer  in women in India. This type of cancer also takes second place among the most common cancer types around the globe, with...

ANPC : 1.1500 (+5.50%)
AnPac Bio Reports Nine Months Ended September 30, 2021, Same Period Achieved Record Revenue Increased By 55.3% While Non-GAAP Net Loss Reduced by 6.8%

PHILADELPHIA, Nov. 26, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology...

ANPC : 1.1500 (+5.50%)
Q4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90+ Companies

Small and Micro-cap investors are invited to attend the Q4 Investor Summit being held on November 16-17, 2021. The event is organized by the Investor Summit Group, recognised as a highly reputed brand...

AZ.TO : 6.19 (unch)
AAZZF : 10.8545 (+0.13%)
ACST : 1.4200 (+7.58%)
ATNM : 5.52 (+0.36%)
ADCO.TO : 0.62 (unch)
ADCOF : 0.4963 (-0.74%)
ALIM : 4.34 (-2.47%)
ACOGF : 0.8943 (-0.56%)
AMST : 1.1700 (+3.54%)
ANVS : 14.57 (+3.92%)
ANPC : 1.1500 (+5.50%)
ARC : 3.54 (-0.28%)
BioMedNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Uniquely Positioned in Cancer Screening, Detection Market

AnPac Bio (NASDAQ: ANPC) , a biotechnology company with operations in China and the United States, is the company behind a proprietary novel technology for early cancer screening and detection — the...

ANPC : 1.1500 (+5.50%)
Veterans Urged to Undergo Lung Cancer Screening During Lung Cancer Awareness Month

Cancer begins when  old cells in an individual’s body  begin to mutate instead of dying, growing out of control and creating abnormal cells. A team of oncologists, cardiothoracic surgeons and specialized...

ANPC : 1.1500 (+5.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AnPac Bio-Medical Science Co., Ltd. is a biotechnology company focused on early cancer screening and detection. AnPac Bio-Medical Science Co., Ltd. is based in China.

See More

Key Turning Points

3rd Resistance Point 1.1700
2nd Resistance Point 1.1500
1st Resistance Point 1.1200
Last Price 1.1500
1st Support Level 1.0700
2nd Support Level 1.0500
3rd Support Level 1.0200

See More

52-Week High 12.0900
Fibonacci 61.8% 7.8574
Fibonacci 50% 6.5500
Fibonacci 38.2% 5.2426
Last Price 1.1500
52-Week Low 1.0100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar